Stephen H. Gillespie

Research interests

Publications

• Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

  The Lancet Respiratory Medicine · 2018 · 10.1016/s2213-2600(18)30078-x

• The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

  Clinical Infectious Diseases · 2018 · 10.1093/cid/ciy026

• A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

  Clinical Pharmacology & Therapeutics · 2017 · 10.1002/cpt.778

• High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  The Lancet Infectious Diseases · 2016 · 10.1016/s1473-3099(16)30274-2

• A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

  American Journal of Respiratory and Critical Care Medicine · 2015 · 10.1164/rccm.201407-1264oc

• Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1407426

• New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

  The Lancet Infectious Diseases · 2014 · https://doi.org/10.1016/s1473-3099(13)70328-1

• Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

  The Lancet Respiratory Medicine · 2013 · 10.1016/s2213-2600(13)70231-5

• Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

  The Lancet Respiratory Medicine · 2013 · 10.1016/s2213-2600(13)70119-x

• Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology

  PLoS Pathogens · 2012 · https://doi.org/10.1371/journal.ppat.1002824

• Blood culture bottle culture of pleural fluid in pleural infection

  Thorax · 2011 · 10.1136/thx.2010.157842

• Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice

  Journal of Medical Microbiology · 2011 · 10.1099/jmm.0.030387-0

• Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

  Clinical Infectious Diseases · 2011 · 10.1093/cid/cir184

• Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

  Journal of Clinical Microbiology · 2011 · 10.1128/jcm.00547-11

• The Bacteriology of Pleural Infection by Genetic and Standard Methods and Its Mortality Significance

  American Journal of Respiratory and Critical Care Medicine · 2006 · 10.1164/rccm.200601-074oc

• Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates

  Journal of Antimicrobial Chemotherapy · 2005 · 10.1093/jac/dki191

• Mandell, Douglas, and Bennett's principles and practice of infectious diseases

  The Lancet Infectious Diseases · 2005 · https://doi.org/10.1016/s1473-3099(05)70159-6

• Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

  The Lancet · 2004 · 10.1016/s0140-6736(04)17442-4

• Attributable Mortality of Nosocomial Candidemia, Revisited

  Clinical Infectious Diseases · 2003 · https://doi.org/10.1086/378745

• The Bactericidal Activity of Moxifloxacin in Patients with Pulmonary Tuberculosis

  American Journal of Respiratory and Critical Care Medicine · 2003 · 10.1164/rccm.200305-682oc

• Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective

  Antimicrobial Agents and Chemotherapy · 2002 · https://doi.org/10.1128/aac.46.2.267-274.2002

• Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis

  Antimicrobial Agents and Chemotherapy · 1999 · 10.1128/aac.43.8.1866

• Activity of moxifloxacin against mycobacteria

  Journal of Antimicrobial Chemotherapy · 1999 · 10.1093/jac/44.3.393

• Gram-positive cocci

  Elsevier eBooks · 1994 · 10.1016/b978-0-7506-0187-0.50007-9

• Medical Microbiology Illustrated

  · 1994

Current projects

No projects listed.